Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

References

• ParamartaJEBaetenDSpondyloarthritis: from unifying concepts to improved treatmentRheumatology (Oxford)20145391547155924369419
   PubMed Web of Science ®Google Scholar
• FendlerCBaraliakosXBraunJGlucocorticoid treatment in spondyloarthritisClin Exp Rheumatol2011295 suppl 68S139S14222018200
   PubMed Web of Science ®Google Scholar
• ChatzikyriakidouAVoulgariPVDrososAAWhat is the role of HLA-B27 in spondyloarthropathies?Autoimmun Rev201110846446821296192
   PubMed Web of Science ®Google Scholar
• ScarpaRPelusoRAttenoMClinical presentation of psoriatic arthritisReumatismo200759suppl 1495117828344
   PubMedGoogle Scholar
• PelusoRDi MinnoMNIervolinoSEnteropathic spondyloarthritis: from diagnosis to treatmentClin Dev Immunol2013201363140823690825
   PubMedGoogle Scholar
• PelusoRIervolinoSVitielloMBrunerVLupoliGDi MinnoMNExtra-articular manifestations in psoriatic arthritis patientsClin Rheumatol201534474575324803233
   PubMed Web of Science ®Google Scholar
• BraunJvan den BergRBaraliakosX2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitisAnn Rheum Dis201170689690421540199
   PubMed Web of Science ®Google Scholar
• SmolenJSBraunJDougadosMTreating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task forceAnn Rheum Dis201473161623749611
   PubMed Web of Science ®Google Scholar
• DougadosMGueguenANakacheJPAnkylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trialRheumatology (Oxford)199938323524410325662
   PubMed Web of Science ®Google Scholar
• SieperJKlopschTRichterMComparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled studyAnn Rheum Dis200867332332917616556
   PubMed Web of Science ®Google Scholar
• van der HeijdeDBarafHSRamos-RemusCEvaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled studyArthritis Rheum20055241205121515818702
   PubMed Web of Science ®Google Scholar
• van der HeijdeDSieperJMaksymowychWP2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritisAnn Rheum Dis201170690590821540200
   PubMed Web of Science ®Google Scholar
• HaibelHFendlerCListingJCallhoffJBraunJSieperJEfficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trialAnn Rheum Dis201473124324623625982
   PubMed Web of Science ®Google Scholar
• CutoloMChronobiology and the treatment of rheumatoid arthritisCurr Opin Rheumatol201224331231822410544
   PubMed Web of Science ®Google Scholar
• SantiagoTJacobsJWSaagKGButtgereitFPereira da SilvaJABalancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritisActa Reumatol Port2015401102225844966
   PubMed Web of Science ®Google Scholar
• RudwaleitMvan der HeijdeDLandeweRThe development of assessment of spondyloarthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selectionAnn Rheum Dis200968677778319297344
   PubMed Web of Science ®Google Scholar
• SmolenJSLandeweRBreedveldFCEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnn Rheum Dis201069696497520444750
   PubMed Web of Science ®Google Scholar
• JonesSDPorterJGarrettSLKennedyLGWhitelockHCalinAA new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI)J Rheumatol199522816097473496
   PubMed Web of Science ®Google Scholar
• Heuft-DorenboschLSpoorenbergAvan TubergenAAssessment of enthesitis in ankylosing spondylitisAnn Rheum Dis200362212713212525381
   PubMed Web of Science ®Google Scholar
• U. S. Food and Drug Administration. [webpage on the Internet]What is a Serious Adverse Event?2016 Available from: http://www.fda.gov/Safety/MedWatch/HowToReport/ucm053087.htmAccessed April 29, 2016
   Google Scholar
• GarrettSJenkinsonTKennedyLGWhitelockHGaisfordPCalinAA new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity IndexJ Rheumatol19942112228622917699630
   PubMed Web of Science ®Google Scholar
• JacobsJWBijlsmaJWGlucocorticoids in rheumatology: indications and routes of administrationClin Exp Rheumatol2011295 suppl 68S81S84
   PubMed Web of Science ®Google Scholar
• StrehlCSpiesCMButtgereitFPharmacodynamics of glucocorticoidsClin Exp Rheumatol2011295 suppl 68S13S18
   PubMed Web of Science ®Google Scholar
• ZenMCanovaMCampanaCThe kaleidoscope of glucorticoid effects on immune systemAutoimmun Rev201110630531021224015
   PubMed Web of Science ®Google Scholar
• GotzschePCJohansenHKShort-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritisCochrane Database Syst Rev20043CD000189
   PubMedGoogle Scholar
• PetersNDEjstrupLIntravenous methylprednisolone pulse therapy in ankylosing spondylitisScand J Rheumatol19922131341381604251
   PubMed Web of Science ®Google Scholar
• BraunJBollowMSeyrekbasanFComputed tomography guided corticosteroid injection of the sacroiliac joint in patients with spondyloarthropathy with sacroiliitis: clinical outcome and follow-up by dynamic magnetic resonance imagingJ Rheumatol19962346596648730123
   PubMed Web of Science ®Google Scholar
• SpiesCMStraubRHCutoloMButtgereitFCircadian rhythms in rheumatology–a glucocorticoid perspectiveArthritis Res Ther201416suppl 2S325608777
   PubMedGoogle Scholar
• AltenRDoringGCutoloMHypothalamus-pituitary-adrenal axis function in patients with rheumatoid arthritis treated with nighttime-release prednisoneJ Rheumatol201037102025203120682671
   PubMed Web of Science ®Google Scholar
• ButtgereitFMehtaDKirwanJLow-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)Ann Rheum Dis201372220421022562974
   PubMed Web of Science ®Google Scholar